July | August 2006 | Applied Biosystems and MDS Sciex announced global availability of a drug discovery application that enables pharmaceutical companies and contract research organizations to more quickly and accurately screen drug candidates. The application, LightSight Software for Metabolite Identification, improves productivity and efficiency of drug discovery scientists analyzing new compounds to treat human disease. This metabolite ID solution enables drug discovery scientists to more quickly examine thousands of drug candidates and determine those that meet the requirements for further development. Companies can then focus valuable resources with greater accuracy on the most promising drug candidates.
Vendor: Applied Biosystems/MDS Sciex
Product: LightSight Software for Metabolite Identification
For more information: www.appliedbiosystems.com